Skip to main content

Dead Leg and its Limit in Water Systems

Dead Leg and its Limit in Water Systems

Dead leg calculation in water system piping and their limits according to world health organization (WHO).

Water system in pharmaceuticals may the source of contamination for the manufactured products. It is necessary to prevent the water system from microbial contamination.

Water is distributed through the pipelines throughout the manufacturing plant. Purified water and water for injection (WFI) is continuously circulated in the circulating loop. It helps the water system to prevent the formation of biofilms.

But there is some space between the circulation loop and the valve at the user points. This section of stagnant water is known as Dead Leg.

Related: Chemical Sanitization of RO Systems and Biofilm Removal 

Long dead legs will have more stagnant water having more microbial growth because the water in the dead leg does not circulate with circulating water. Therefore dead legs should be short.

According to WHO: TRS 929 (Page 54), dead-leg should not be more than 1.5 times 3 times (updated in TRS 970 page 83) of internal diameter (ID) of the pipe. Nowadays no dead leg pipelines are installed to solve the water staging problems in water systems.

Also see: Water Storage and Distribution System

Comments

Popular posts from this blog

Sterility Testing by Direct Inoculation Method

Sterility Testing by Direct Inoculation Method Direct Inoculation Method Learn the procedure for sterility test for sterile pharmaceutical products by direct inoculation method. 1.0 Objective :  To lay down Standard Operating Procedure is to provide guidelines for sterility testing by Direct Inoculation Method. 2.0 Scope This procedure is applicable for the products manufactured at the location which can not be tested by Membrane Filtration Method. 3.0 Responsibility Implementation: Microbiologist 4.0 Accountability Execution: Manager - QC Review & Approval : AGM - QA / QC Procedure Direct Inoculation Method Sample for Finished Products: Collect the samples to be tested for sterility. Out of the whole sample, randomly select 20 articles of each lot of batch for both LVP and SVP t erminal ly sterilized products and for aseptically filled products.    Sample for Intermediates: Randomly collect 16 pre-sterilized bottle samples to be tested for sterility from LVP bot...

SOP for Washing of HPLC Column After Use

SOP for Washing of HPLC Column After Use Standard operating procedure to wash the HPLC column after analysis. 1.0 OBJECTIVE To clean the column thoroughly after its each use to avoid any interference on repeated usage. 2.0 SCOPE This procedure is applicable for different groups of H.P.L.C columns used in Quality Control laboratory. 3.0 RESPONSIBILITY 2.1 Doing: Technical Assistant 2.2 Checking: Executive /Manager 4.0 ACCOUNTABILITY Head of the Department 5.0 PROCEDURE 5.1 For C18, C8, C6, Phenyl, (CN, Amine, Silica column.:) 5.1.1 Wash the column with the solvent which is use in individual product mobile phase preparation. eg. suppose water is use in mobile phase  preparation then wash the column with water. 5.1.2 Allow the minimum 30 ml washing medium to flow through the column. 5.1.3 Disconnect the column from the HPLC unit and store in an allocated place. 5.2 For Protein pack column: 5.2.1 Wash the column with minimum 30 ml of 2.5 M acetic acid. 5.2.4 Disconnect the column from ...

Blow Fill Seal (BFS) and Form Fill Seal (FFS) Technology in Sterile Manufacturing

Blow Fill Seal (BFS) and Form Fill Seal (FFS) Technology in Sterile Manufacturing Know about sterile pharmaceutical production using Blow Fill Seal (BFS) and Form Fill Seal (FFS) technology. Both of these techniques are used to manufacture  sterile pharmaceutical products   as parenteral (LVP & SVP), infusions, ophthalmic and inhalation products. These are automated techniques to prepare sterile products. The basic concept of the  FFS   and BFS is to reduce the  contamination   by forming the container, filling and sealing in a closed sterile chamber of the machine. There is no personnel intervention to reduce the chances of the contamination during the manufacturing of sterile products. It gives more production at very low operational cost with the high assurance of  sterility . Blow fill seal technology is widely used and accepted by the various pharmaceutical regulatory authorities as US-FDA and MHRA. The system is being used for over 30 years a...

Aseptic Filling Process (Media Fill) Validation Protocol in Sterile Pharmaceuticals

Aseptic Filling Process (Media Fill) Validation Protocol in Sterile Pharmaceuticals Validation of sterile manufacturing process by media fill validation test as per PICS guidelines for aseptic validation or aseptic process simulation. 1.0 OBJECTIVE 1.1 To define procedures for validating and maintaining the validation of all aseptic filling processes and qualification of the quality of the product by system/facility/equipment. 2.0 SCOPE 2.1 This procedure applies to all aseptically filled sterile products intended for human use. 3.0 RESPONSIBILITY 3.1 The Validation personnel coordinate the aseptic filling validation program and write the sterile media aseptic filling processes reports. 3.2 Manufacturing personnel the sterile media aseptic filling processes and performs the sterile media fills. 3.3 QA personnel perform the sampling and assist with the IPQA monitoring required for each sterile media fill. 3.4 QC personnel to perform the testing and assist with the monitoring required fo...

Media Fill Test for Sterile API Manufacturing Process

Media Fill Test for Sterile API Manufacturing Process Know about the process simulation test for the active pharmaceutical ingredient (API) manufacturing process. Media fill test is done to verify the sterility of the sterile manufacturing process. Media fill validation for sterile API is different from the sterile formulation media fill. There are different processes in the sterile API manufacturing as filtration, crystallization, drying, milling etc. These all are different from the sterile formulation process where the sterile material is filled in sterile containers in aseptic conditions . Lactose powder is used in the process simulation. The whole media fill process is carried out in two phases 1) Wet Phase  2) Dry phase 1) Wet Phase:   Non-sterile lactose powder is used in the wet phase. Wet phase simulates the liquid processing steps of the manufacturing process  i.e. aseptic filtration of lactose solution from controlled area reactor to cryst...